Astria Therapeutics to Present STAR-0215 at the 2023 European Academy of Allergy, Asthma, and Immunology Annual Meeting
Astria Therapeutics, Inc. , a biopharmaceutical company developing STAR-0215 for the treatment of hereditary angioedema and focused on life-changing therapies for rare and niche allergic and... | June 5, 2023
United States William Lumry Nikolaos Biris Marcus Maurer Assay Development At Astria Therapeutics Astria Therapeutics Inc
Source: marketscreener.com